CytomX Therapeutics Company
CytomX is an Xtraordinary clinical-stage biopharmaceutical company with a unique approach to treating cancer and a team dedicated to make a difference. CytomX has five Probody® programs in the clinic, the goal is to reinvent therapeutic antibodies for the treatment of cancer.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Register and Claim Ownership